TLTFF — THERALASE TECHNOLOGIES INC /FI
—
OTC ·
Unknown ·
Unknown ·
CIK 923883 ·
Last close
$0.12
Market Cap
—
52W High
$0.31
52W Low
$0.10
ADV30
175,507
Next earnings
2026-11-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 164,293 | 85,562 | -1,063,363 | -1,062,141 | 8,126,034 | 5,260,832 | 1,283,902 |
| Mar 2026 | 132,634 | 64,384 | -1,030,426 | -1,031,785 | 3,890,292 | 1,003,943 | 1,940,474 |
| Dec 2025 | 225,895 | 216,301 | -692,519 | -685,672 | 3,494,628 | 182,914 | 1,716,812 |
| Sep 2025 | 279,640 | 158,864 | -1,019,993 | -1,011,911 | 3,004,348 | 80,987 | 1,911,635 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-3,389,869
Investing CF
$25,067
Financing CF
$8,579,308
CapEx
$-31,833
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.02
As of
2026-09-06
Balance + Analyst (yfinance extras)
Retained Earnings
$-73,710,862
Inventory
$464,138
Receivables
$846,667
ST Investments
—
EBIT TTM
$-3,731,374
Pretax Income TTM
$-3,791,506
Interest Exp TTM
$60,132
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 816,468 | -4,175,338 | -4,120,817 | 3,494,628 | 1,716,812 | 1,777,816 | -3,285,750 |
| Dec 2024 | 1,033,431 | -4,288,350 | -4,256,114 | 3,246,949 | 1,179,501 | 2,067,448 | -3,350,201 |
| Dec 2023 | 1,070,307 | -4,594,266 | -4,570,879 | 3,276,806 | 1,371,364 | 1,905,442 | -4,072,806 |
| Dec 2022 | 1,138,569 | -5,231,544 | -5,235,302 | 4,160,904 | 1,068,336 | 3,092,568 | -5,102,894 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BRRN | Bryn Inc. | $945.00B | $2100.00 | — |
| SPY | SPDR S&P 500 ETF TRUST | $707.93B | $771.35 | — |
| TMO | THERMO FISHER SCIENTIFIC INC. | $249.58B | $675.00 | — |
| KLAC | KLA CORP | $245.53B | $187.92 | — |
| IBM | INTERNATIONAL BUSINESS MACHINES CORP | $212.46B | $225.51 | — |
News headlines (Yahoo Finance, 1h cache)
Correcting and Replacing: Theralase(R) Releases Q2 2026 Financial Statements
2026-09-18 11:00 · Yahoo
Theralase(R) Commences GLP Toxicology Analysis of Rutherrin(R)
2026-09-15 11:00 · Yahoo
Theralase(R) Releases Q2 2026 Financial Statements
2026-08-28 20:36 · Yahoo
Theralase(R) Grants Stock Options
2026-08-07 21:25 · Yahoo
Theralase(R) Engages Global One Media to Expand Global Investor Awareness
2026-08-04 11:00 · Yahoo
Theralase(R) Receives Receipt for C$100 Million Base Shelf Prospectus
2026-06-30 20:30 · Yahoo
Theralase(R) Lists Warrants on the TSXV
2026-06-03 11:00 · Yahoo
Theralase(R) Releases Q1 2026 Financial Statements
2026-05-29 21:04 · Yahoo
Theralase(R) Releases 2025 Annual Financial Statements and Provides Clinical Study Update
2026-05-04 21:22 · Yahoo
Theralase(R) Closes $CAN 2.66 Million Financing
2026-04-10 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.